Benzinga | Jul 28, 2021 04:49PM EDT

CORRECTION: Soleno Therapeutics Q2 EPS $(0.25) Down From $(0.16) YoY

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.25) per share. This is a 56.25 percent decrease over losses of $(0.16) per share from the same period last year.